Virtual Health Partnerships Associate

Privia Health faces challenges despite 24% revenue growth, according to investment research firm StockStory. The healthcare technology company, which operates across 13 US states with over 4,300 providers, struggles with a modest $2.36 billion revenue base and weak 4.7% free cash flow margin over five years. StockStory notes Privia's growth push has led to negative returns on capital. The stock trades at $19.63 per share, or 18 times forward price-to-earnings. In contrast, StockStory highlighted Bloom Energy and First Advantage as promising growth investments. Bloom Energy achieved 91% year-on-year revenue growth and has moved to positive free cash flow. First Advantage grew revenue 32.9% annually, processing over 200 million background screens across 200 countries.

Privia Health announces appointment of Opella Ernest, M.D. to its Board of Directors. MWN-AI** Summary. Privia Health Group, Inc. has announced the appointment of Dr. Opella Ernest to its Board of Directors, effective September 1, 2026. Dr. Ernest's appointment is expected to enhance Privia Health's strategic direction, particularly as the company continues to expand its provider networks across the United States. David King, Chairman of the Board, expressed enthusiasm for Dr. Ernest's extensive clinical expertise and value-based care experience, which aligns with Privia's mission to improve healthcare delivery. With over 20 years of healthcare executive experience, Dr. Ernest currently serves as President of HCSC Markets at Health Care Service Corporation, where she oversees strategic direction and performance across all market segments. Her previous roles include Executive Vice President and COO at HCSC, during which she spearheaded technology-driven enhancements to customer and provider experiences. Prior to her tenure at HCSC, she held leadership positions at Healthspring and various clinical practices. Dr. Ernest is a board-certified family physician, having earned her medical degree from The Ohio State University College of Medicine and a bachelor's degree from the University of Michigan. Beyond her corporate roles, she actively participates on the boards of World Business Chicago and the Museum of Science and Industry. She has also served as chair of the American Heart Association's Metro Chicago board, receiving the 2021 Heart of Gold Award for her contributions to addressing health issues. Privia Health is recognized as a leading physician enablement company, operating in 25 states and the District of Columbia. The company focuses on building robust provider networks and optimizing the practices of over 1,300 physicians, aiming to enhance patient care and lower costs while promoting the health and well-being of communities. MWN-AI** Analysis. Privia Health Group, Inc. (Nasdaq: PRVA) has recently announced the appointment of Dr. Opella Ernest to its Board of Directors, signifying a strategic move that could potentially enhance the company's operational efficacy and market position. Dr. Ernest brings over 20 years of healthcare executive experience, notably in value-based care and clinical operations, which aligns seamlessly with Privia's mission to optimize healthcare delivery. Dr. Ernest's previous role as President of HCSC Markets underscores her capacity to drive growth and innovation through technology, a critical component for companies navigating the evolving healthcare landscape. Her experience in transforming customer and provider experiences could prove invaluable as Privia continues to expand its scaled provider networks. For investors, this appointment indicates a commitment to enhancing management expertise, offering confidence in the future direction of the company. Privia Health operates as one of the nation's largest physician enablement companies, serving an extensive network of over 1,300 physician practices and impacting more than 6.1 million patients. The company's strategic emphasis on building strong partnerships across medical groups and health plans positions it well for sustainable growth amid increasing demand for cost-effective healthcare solutions. From a market perspective, this development could signal an uptick in stock performance as investor sentiment may positively react to enhanced leadership and strategic growth initiatives. However, potential investors should remain cognizant of the inherent risks associated with healthcare investments - including regulatory changes, competitive pressures, and market fluctuations. As Privia Health continues to leverage technology and leadership to improve health outcomes and provider well-being, investors would do well to monitor the execution of Dr. Ernest's initiatives and overall corporate performance in the dynamic healthcare sector. **MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release. August 18, 2026 09:00:00 am ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) - Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026. She has also been named a member of the Compliance Committee of the Board. "We are excited to welcome Dr. Ernest to our Board of Directors," said David King, Chairman of the Board, Privia Health Group, Inc. "She brings valuable clinical expertise and value-based care experience to the Board and her deep healthcare expertise will be beneficial to Privia Health as we continue to grow our business and build scaled provider networks across the United States." Dr. Ernest has over 20 years of healthcare executive experience. Since 2023, she has served as President, HCSC Markets at Health Care Service Corporation, responsible for the strategic direction, clinical operations, performance, and growth for all market segments. She served as Executive Vice President, Chief Operating Officer at HCSC from 2021 to 2023, transforming HCSC's customer and provider experience through advancements in technology and innovation. Prior to joining HCSC in 2012, Dr. Ernest held leadership roles at Healthspring and in various clinical practices. A board-certified family physician, Dr. Ernest has a degree in medicine from The Ohio State University College of Medicine and a bachelor's degree from the University of Michigan. Dr. Ernest is a member of the boards of directors of World Business Chicago and the Museum of Science and Industry. She is the former Chair of the American Heart Association's Metro Chicago board of directors and received the 2021 Heart of Gold Award for her dedication addressing health issues. About Privia Health Privia Health(TM) is one of the largest physician enablement companies in the United States with a presence in 25 states and the District of Columbia. Privia builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. Privia collaborates with medical groups, health plans and health systems to optimize 1,300+ physician practices, improve the patient experience for 6.1+ million patients, and reward 5,600+ physicians and advanced practitioners for delivering high-value care. Privia's mission is to transform healthcare delivery to achieve better outcomes, lower costs, and improve the health of communities and the well-being of providers. For more information, visit priviahealth.com and connect with Market Wire News on LinkedIn. Safe Harbor Statement This release may contain forward-looking statements within the meaning of the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the Company's control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in filings with the Securities and Exchange Commission ("SEC"), including those under "Risk Factors" therein. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Forward-looking statements speak only as of the date made. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Contact: Robert Borchert SVP, Investor & Corporate Communications [email protected] 817.783.4841 FAQ**. How will the appointment of Dr. Opella Ernest to the Board of Privia Health Group Inc. (PRVA) influence the company's strategic direction and growth in value-based care? Dr. Opella Ernest's appointment to the Board of Privia Health Group Inc. (PRVA) is expected to enhance the company's strategic direction and growth in value-based care by leveraging her extensive experience in healthcare management and innovation in patient-centered solutions. With Dr. Ernest's extensive background in clinical operations, how does Privia Health Group Inc. (PRVA) plan to leverage her expertise to enhance its provider networks? Privia Health Group Inc. (PRVA) plans to leverage Dr. Ernest's extensive background in clinical operations to optimize and expand its provider networks through improved operational efficiencies, enhanced quality of care, and strategic partnerships. Can Privia Health Group Inc. (PRVA) provide insights into how Dr. Ernest's experience will impact its mission to improve healthcare delivery and outcomes for patients? Dr. Ernest's experience is likely to enhance Privia Health Group Inc.'s mission by leveraging his expertise to optimize healthcare delivery and patient outcomes through innovative strategies and improved operational efficiencies. What specific initiatives does Privia Health Group Inc. (PRVA) envision under Dr. Ernest's leadership on the Compliance Committee to ensure adherence to healthcare regulations? Privia Health Group Inc., under Dr. Ernest's leadership on the Compliance Committee, aims to enhance adherence to healthcare regulations through robust compliance training programs, automated monitoring systems, and regular audits to ensure ethical practices and regulatory alignment. **MWN-AI FAQ is based on asking OpenAI questions about Privia Health Group Inc. (NASDAQ: PRVA).